CSI Market
Sign In | Register

Verrica Pharmaceuticals Inc (VRCA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access VRCA quarterly Cash Flow →
This page allows investors to follow Verrica Pharmaceuticals Inc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-17.89
Depreciation & amortization0.13
Amortization of Other Assets0.00
Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.25
Share-based Compensation3.32
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt1.53
Operating Lease Right Of Use Asset Amortization-
Increase Decrease In Accrued Expenses And Other Current Liabilities-1.31
Non Cash Interest Expense2.48
Operating Lease Right Of Use Asset Amortization Expense0.30
Gain Loss On Termination Of Lease0.00
Derivative Gain Loss On Derivative Net-2.65
Increase Decrease In License And Collaboration Receivable Billed And Unbilled0.78
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-5.21
Increase (Decrease) in Accounts Payable0.18
Increase (Decrease) in Accrued Liabilities0.00
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.26
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.73
Discontinued operations0.00
Net Cash flow from Operating Activities-17.63
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Deposit For Construction Of Equipment-
Increase Decrease In Deposits Investing Activity-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-12.90
Long-term debt - borrowings0.00
Long-term debt - repayments-35.03
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net50.07
Noncash Or Part Noncash Acquisition Value Of Assets Acquired-
Deferred Offering Costs Included In Accounts Payable And Accrued Expense-
Proceeds From Issuance Of Debt Net-
Repayment Of Subscription Receivable-
Finance Lease Principal Payments-0.38
Equity Issuance Costs-0.31
Proceeds From Issuance Of Common Stock And Pre Funded Warrants Net Of Issuance Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.45
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-17.63
Total Cash Flow-16.18
4 historic quarters locked

Sign in to unlock the full Verrica Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Verrica Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001660334-26-000008

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License